Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]

por Curtis, Sean P, Bockow, Barry, Fisher, Chester, Olaleye, Joseph, Compton, Amy, Ko, Amy T, Reicin, Alise S
Publicado 2005